JP2015505244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505244A5 JP2015505244A5 JP2014549503A JP2014549503A JP2015505244A5 JP 2015505244 A5 JP2015505244 A5 JP 2015505244A5 JP 2014549503 A JP2014549503 A JP 2014549503A JP 2014549503 A JP2014549503 A JP 2014549503A JP 2015505244 A5 JP2015505244 A5 JP 2015505244A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- peptide
- antigen
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161580837P | 2011-12-28 | 2011-12-28 | |
| EP11195952.4 | 2011-12-28 | ||
| US61/580,837 | 2011-12-28 | ||
| EP11195952 | 2011-12-28 | ||
| PCT/EP2013/050024 WO2013098419A1 (en) | 2011-12-28 | 2013-01-02 | Method of providing monoclonal auto-antibodies with desired specificity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505244A JP2015505244A (ja) | 2015-02-19 |
| JP2015505244A5 true JP2015505244A5 (https=) | 2016-01-21 |
| JP6242808B2 JP6242808B2 (ja) | 2017-12-06 |
Family
ID=48696366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014549503A Expired - Fee Related JP6242808B2 (ja) | 2011-12-28 | 2013-01-02 | 所望の特異性を有するモノクローナル自己抗体を提供する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9475872B2 (https=) |
| EP (3) | EP2797952B1 (https=) |
| JP (1) | JP6242808B2 (https=) |
| AU (3) | AU2013206789B2 (https=) |
| CA (2) | CA2861793C (https=) |
| DK (1) | DK2797951T3 (https=) |
| ES (2) | ES2668104T3 (https=) |
| HU (1) | HUE037186T2 (https=) |
| PL (2) | PL2797951T3 (https=) |
| PT (1) | PT2797951T (https=) |
| SI (1) | SI2797952T1 (https=) |
| WO (2) | WO2013098420A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10131709B2 (en) | 2011-12-28 | 2018-11-20 | Immunoqure Ag | Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 |
| EP2626367A1 (en) * | 2012-02-10 | 2013-08-14 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Method for obtaining three-dimensional actin structures and uses thereof |
| WO2014093786A1 (en) * | 2012-12-14 | 2014-06-19 | Abbvie, Inc. | Methods for increasing the efficiency of hybridoma generation |
| WO2015001047A1 (en) | 2013-07-03 | 2015-01-08 | Immunoqure Ag | Method of providing anti-human cytokine antibodies for pharmaceutical use |
| JP6742237B2 (ja) | 2013-07-03 | 2020-08-19 | イムノキュア アーゲーＩｍｍｕｎｏｑｕｒｅ Ａｇ | ヒト抗ｉｆｎ−アルファ抗体 |
| AU2014286128B2 (en) | 2013-07-03 | 2019-10-10 | Immunoqure Ag | Human anti-IL-32 antibodies |
| EP2863231A1 (en) * | 2013-10-17 | 2015-04-22 | Institut D'Investigaciones Biomédiques August Pi i Sunyer | Diagnostic method for detecting a GABA(A) related autoimmune disease and related subject-matter |
| JP2017527262A (ja) * | 2014-07-03 | 2017-09-21 | イムノキュア アーゲーＩｍｍｕｎｏｑｕｒｅ Ａｇ | ヒト由来抗ｉｌ−２０抗体および抗サイトカイン抗体同定アッセイ |
| KR102441107B1 (ko) * | 2014-11-07 | 2022-09-13 | 후지쿠라 가세이 가부시키가이샤 | 데옥시하이푸신·신타제 유전자를 지표로서 사용하는 동맥 경화 및 암의 검출 방법 |
| FI3277321T3 (fi) | 2015-04-01 | 2024-10-31 | Anaptysbio Inc | T-soluimmunoglobuliinia ja musiiniproteiini 3:a (tim-3) vastaan suunnattuja vasta-aineita |
| CN115925932A (zh) | 2015-04-15 | 2023-04-07 | 安奈普泰斯生物有限公司 | 针对白细胞介素36受体（il-36r）的抗体 |
| RU2018109230A (ru) * | 2015-08-17 | 2019-09-19 | ДОЙЧЕС ЦЕНТРУМ ФЮР НОЙРОДЕГЕНЕРАТИВЕ ЭРКРАНКУНГЕН е.Ф. (ДЦНЭ) | Антитело, или фрагмент антитела, или неиммуноглобулиновый каркас, связывающийся с областью связывания антитела против рецептора n-метил-d-аспартата (nmda) |
| FR3050535B1 (fr) * | 2016-04-25 | 2020-11-13 | Hospices Civils Lyon | Anticorps anti il17 |
| WO2018017996A1 (en) * | 2016-07-22 | 2018-01-25 | University Of Washington | Identification and production of high affinity igm antibodies and derivatives thereof |
| MX2019005116A (es) | 2016-11-01 | 2019-11-12 | Anaptysbio Inc | Anticuerpos dirigidos contra la proteina de inmunoglobulina de linfocitos t y de mucina 3 (tim-3). |
| WO2018129553A1 (en) | 2017-01-09 | 2018-07-12 | Tesaro, Inc. | Methods of treating cancer with anti-tim-3 antibodies |
| US11619832B2 (en) | 2018-03-08 | 2023-04-04 | Coopervision International Limited | Identification of contact lens wearers predisposed to contact lens discomfort |
| PH12021551475A1 (en) | 2019-01-07 | 2022-05-02 | Shattuck Labs Inc | Heterodimeric proteins for modulating gamma delta t cells |
| US11098093B2 (en) | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
| WO2021250323A1 (en) * | 2020-06-09 | 2021-12-16 | Helsingin Yliopisto | Anti-cox-2 autoantibody as a diagnostic marker, and methods, kits and uses related thereto |
| EP4305190A4 (en) | 2021-03-11 | 2025-03-26 | Iggenix, Inc. | METHODS AND SYSTEMS FOR PREDICTING AN ALLERGIC REACTION |
| WO2023213400A1 (en) * | 2022-05-05 | 2023-11-09 | Institute For Research In Biomedicine | Antibodies against chemokines, method for identifying said antibodies and uses thereof |
| CN115724983B (zh) * | 2022-10-10 | 2023-09-19 | 宝船生物医药科技(上海)有限公司 | 一种针对抗csf1r单克隆抗体的抗独特型抗体及其应用 |
| TW202540204A (zh) | 2024-01-26 | 2025-10-16 | 西班牙商阿爾米雷爾有限公司 | 雙特異性分子及使用其的治療方法 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| ATE243754T1 (de) | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| WO1989009622A1 (en) | 1988-04-15 | 1989-10-19 | Protein Design Labs, Inc. | Il-2 receptor-specific chimeric antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| GB9020282D0 (en) | 1990-09-17 | 1990-10-31 | Gorman Scott D | Altered antibodies and their preparation |
| DK9091D0 (da) | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
| DE4130786A1 (de) * | 1991-09-16 | 1993-03-18 | Symbiotec Gmbh | Peptide zur herstellung von mitteln zur diagnose und therapie von systemischen lupus |
| JP2006008694A (ja) * | 1991-09-16 | 2006-01-12 | Symbiotec Ges Zur Forschung & Entwicklung Au F Dem Gebiet Der Biotechnologie Mbh | 全身性エリテマトーデスの診断、治療製剤製造用ペプチド |
| DE69233408T2 (de) | 1991-12-02 | 2005-09-22 | Cambridge Antibody Technology Ltd., Melbourn | Herstellung von Antikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken. |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| ES2123062T3 (es) | 1992-08-21 | 1999-01-01 | Biogen Inc | Polipeptidos de transporte derivados de la proteina tat. |
| US6309636B1 (en) | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0776906A3 (de) * | 1995-10-19 | 1998-02-25 | Imtec Immundiagnostika Gmbh | Peptide des Antigens Sm-D und ihre Verwendung, insbesondere für die Diagnostik des SLE |
| US6590079B2 (en) | 1997-01-30 | 2003-07-08 | Ixsys, Incorporated | Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same |
| FI973762A0 (fi) | 1997-09-23 | 1997-09-23 | Krohn Kai | Ny gen |
| US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US6531580B1 (en) | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
| US6849425B1 (en) | 1999-10-14 | 2005-02-01 | Ixsys, Inc. | Methods of optimizing antibody variable region binding affinity |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| US7638604B2 (en) * | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
| US20030044870A1 (en) | 2001-07-13 | 2003-03-06 | Peter Sehr | Generic capture elisa using recombinant fusion proteins for detecting antibodies in biological samples |
| ATE534669T1 (de) * | 2002-05-28 | 2011-12-15 | Omrix Biopharmaceuticals Inc | Verfahren zum erhalten von anti-idiotyp antikörpern |
| US20040101909A1 (en) | 2002-08-20 | 2004-05-27 | Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 | Purification of polyreactive autoantibodies and uses thereof |
| AU2004215125B2 (en) | 2003-02-26 | 2011-01-06 | Institute For Research In Biomedicine | Monoclonal antibody production by EBV transformation of B cells |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| US7158410B2 (en) | 2004-08-27 | 2007-01-02 | Micron Technology, Inc. | Integrated DRAM-NVRAM multi-level memory |
| BRPI0619908A2 (pt) | 2005-12-16 | 2011-10-25 | Ribovax Biotechnologies Sa | método para imortalização de uma população de células, população de células, população de células oligoclonal ou monoclonal, cultura celular, sobrenadante de uma cultura celular, biclioteca de dnas, uso de uma população de células, cultura celular, sobrenadante ou biblioteca de dnas, kit para identificar e produzir um anticorpo monoclonal, método para produzir uma cultura celular, e método para produzir um anticorpo monoclonal |
| EP1996622A2 (en) * | 2006-03-10 | 2008-12-03 | Zymogenetics, Inc. | Antibodies that bind both il-17a and il-17f and methods of using the same |
| TW200815469A (en) | 2006-06-23 | 2008-04-01 | Astrazeneca Ab | Compounds |
| JP4059404B2 (ja) * | 2006-09-22 | 2008-03-12 | 栄研化学株式会社 | 甲状腺機能を刺激する活性を持つ抗体 |
| WO2008081008A1 (en) | 2007-01-05 | 2008-07-10 | University Of Zurich | Method of providing disease-specific binding molecules and targets |
| EP2457928B1 (en) | 2007-03-13 | 2017-05-10 | Universität Zürich | Monoclonal human tumor-specific antibody |
| WO2009055711A2 (en) * | 2007-10-25 | 2009-04-30 | Trellis Bioscience, Inc. | Anti-rsv g protein antibodies |
| GB0807413D0 (en) * | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
| RU2474588C2 (ru) * | 2008-05-05 | 2013-02-10 | Новиммун Са | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения |
| EP2307453A1 (en) * | 2008-06-16 | 2011-04-13 | University Of Zurich | Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| CN102317316B (zh) | 2008-12-19 | 2014-08-13 | 帕尼玛制药股份公司 | 人抗α突触核蛋白自身抗体 |
| CN102458437B (zh) * | 2009-05-05 | 2015-06-10 | 诺维莫尼公司 | 抗il-17f抗体及其使用方法 |
| EP2258727A1 (en) | 2009-05-27 | 2010-12-08 | Wezen Biopharmaceuticals S.r.l. A Socio Unico | Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders |
-
2013
- 2013-01-02 WO PCT/EP2013/050026 patent/WO2013098420A1/en not_active Ceased
- 2013-01-02 US US14/369,467 patent/US9475872B2/en not_active Expired - Fee Related
- 2013-01-02 HU HUE13700002A patent/HUE037186T2/hu unknown
- 2013-01-02 CA CA2861793A patent/CA2861793C/en active Active
- 2013-01-02 ES ES13700002.2T patent/ES2668104T3/es active Active
- 2013-01-02 CA CA2861695A patent/CA2861695C/en active Active
- 2013-01-02 JP JP2014549503A patent/JP6242808B2/ja not_active Expired - Fee Related
- 2013-01-02 ES ES19159201T patent/ES2964168T3/es active Active
- 2013-01-02 AU AU2013206789A patent/AU2013206789B2/en not_active Ceased
- 2013-01-02 PT PT137000022T patent/PT2797951T/pt unknown
- 2013-01-02 EP EP13700013.9A patent/EP2797952B1/en active Active
- 2013-01-02 WO PCT/EP2013/050024 patent/WO2013098419A1/en not_active Ceased
- 2013-01-02 AU AU2013206788A patent/AU2013206788B2/en not_active Ceased
- 2013-01-02 PL PL13700002T patent/PL2797951T3/pl unknown
- 2013-01-02 SI SI201331457T patent/SI2797952T1/sl unknown
- 2013-01-02 US US14/368,749 patent/US9957319B2/en active Active
- 2013-01-02 DK DK13700002.2T patent/DK2797951T3/en active
- 2013-01-02 EP EP13700002.2A patent/EP2797951B1/en active Active
- 2013-01-02 EP EP19159201.3A patent/EP3546481B1/en active Active
- 2013-01-02 PL PL13700013T patent/PL2797952T3/pl unknown
-
2017
- 2017-06-29 AU AU2017204449A patent/AU2017204449A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015505244A5 (https=) | ||
| US12410256B2 (en) | Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases | |
| RU2474588C2 (ru) | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения | |
| Van Blarcom et al. | Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencing | |
| US20210230269A1 (en) | Immune-stimulating monoclonal antibodies against human interleukin-2 | |
| US9127057B2 (en) | Anti-IL-23 heterodimer specific antibodies | |
| RU2016136639A (ru) | Антитела против эотаксина 2, которые распознают дополнительные связывающие CCR3 хемокины | |
| RU2018111508A (ru) | Анти-LAG-3 антитела | |
| RU2011149334A (ru) | Анти-il-17f антитела и способы их применения | |
| JP2018121657A5 (https=) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| Schaller et al. | The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs | |
| RU2015104760A (ru) | Связывающие kir3dl2 агенты | |
| JP2020536488A5 (https=) | ||
| RU2015103228A (ru) | Антитела против тау | |
| JP2015530971A5 (https=) | ||
| JP2026065087A (ja) | 操作されたｃｄ２５ポリペプチドおよびその使用 | |
| RU2017107773A (ru) | Антитела, специфичные к ммр9 | |
| RU2013133846A (ru) | Антитела против il-18 и их применение | |
| JP2016503293A5 (https=) | ||
| JP2012524524A5 (https=) | ||
| CN116554323B (zh) | 人源化抗il21抗体的开发和应用 | |
| TW201625947A (zh) | 測定ｆｖｉｉｉ的反應性之方法 | |
| JP2023510844A5 (https=) | ||
| AU2022237556A9 (en) | Stem cell factor antibodies and methods of use thereof |